Science
Mechanism of Action
The 'sh-decapeptide-9' component, structurally identical to human endorphin, functions by activating the skin's intrinsic repair mechanisms. In vitro investigations reveal its capacity to enhance epidermal regeneration and stimulate the synthesis of collagen types I and III, alongside other vital skin proteins, thereby improving structural integrity. The 'nicotinoyl' moiety is hypothesized to contribute antioxidant and protective benefits to the skin, complementing the peptide's regenerative actions.
Research
Clinical Evidence
Low confidenceN/A
Transparency
Dusting Analysis
The Formula
Formulation
Safety
Safety Profile
While NICOTINOYL SH-DECAPEPTIDE-9 itself has not been reviewed by organizations like CIR, related peptides, such as Cyclized Hexapeptide-9, are recognized for their exceptionally high safety profiles. Preliminary testing on a similar novel peptide with nicotinic activity reported it to be non-irritating and non-allergenic, suggesting a favorable safety outlook.
Your Skin
Skin Compatibility
Our Assessment
Verdict
This advanced peptide demonstrates significant potential for enhancing skin regeneration and structural integrity based on robust mechanistic and in vitro data, positioning it as a valuable asset for targeted anti-aging formulations.
Related
Similar Ingredients
Finding similar ingredients…